Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Vision Disorders 1Pituitary Neoplasms 1Mediastinal Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Glioma 1Breast Neoplasms 1

Interventions

Temozolomide 16Radiotherapy 7apatinib 5anlotinib 3Surgical Procedures, Operative 3Chlorotoxin 3Bevacizumab 3Positron Emission Tomography Computed Tomography 2Pemetrexed 2Magnetic Resonance Spectroscopy 2Lomustine 2Irinotecan 2Immunotherapy, Adoptive 2Blood Specimen Collection 2Aminolevulinic Acid 2vandetanib 1sodium thiosulfate 1ribociclib 1poly ICLC 1lonafarnib 1lentiviral minigene vaccine of COVID-19 coronavirus 1etoposide phosphate 1Vinblastine 1Valproic Acid 1Tranexamic Acid 1Surveys and Questionnaires 1Sunitinib 1Rivaroxaban 1Radiosurgery 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Glioma × Diffusion Tensor Imaging × Clear all
NCT00330109 2017-01-16

Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology

AHS Cancer Control Alberta

Phase NA Unknown
113 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡